Symphogen
Mathilde Bolding Andreasen has work experience in various roles and companies. From November 2021 to the present, they have been employed as a Scientist at Symphogen. Prior to this, they worked as a Studentermedhjælper at Symphogen from August 2016 to June 2021. Mathilde also served as a Novo Science Ambassador at Danish Science Factory from January 2016 to 2017. Additionally, they were a Projektleder at Biotech Academy from June 2015 to March 2016.
Mathilde Bolding Andreasen attended Rysensteen Gymnasium from 2010 to 2013. Mathilde then went on to complete their Bachelor's degree in Biochemistry at Københavns Universitet - University of Copenhagen from 2014 to 2019.
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.